TY - JOUR
T1 - Temporal changes in mRNA expression of the brain nutrient transporters in the lithium-pilocarpine model of epilepsy in the immature and adult rat
AU - Leroy, Claire
AU - Pierre, Karin
AU - Simpson, Ian A.
AU - Pellerin, Luc
AU - Vannucci, Susan J.
AU - Nehlig, Astrid
N1 - Funding Information:
This study was supported by grants from the Institut National de la Santé et de la Recherche Médicale ( U 398 ), the Fondation pour la Recherche Médicale , a UNESCO grant (CL), and NIH / HD30704 (SJV), NIH/ NS41405 (IAS) grants. LP is supported by the Fonds National de la Recherche Suisse , grant No. 31003A-125063 . The excellent technical assistance of Estelle Koning, Arielle Ferrandon, Lisa Willing, and Marianne Klinger is gratefully acknowledged.
PY - 2011/9
Y1 - 2011/9
N2 - The lithium-pilocarpine model mimics most features of human temporal lobe epilepsy. Following our prior studies of cerebral metabolic changes, here we explored the expression of transporters for glucose (GLUT1 and GLUT3) and monocarboxylates (MCT1 and MCT2) during and after status epilepticus (SE) induced by lithium-pilocarpine in PN10, PN21, and adult rats. In situ hybridization was used to study the expression of transporter mRNAs during the acute phase (1, 4, 12 and 24 h of SE), the latent phase, and the early and late chronic phases. During SE, GLUT1 expression was increased throughout the brain between 1 and 12 h of SE, more strongly in adult rats; GLUT3 increased only transiently, at 1 and 4 h of SE and mainly in PN10 rats; MCT1 was increased at all ages but 5-10-fold more in adult than in immature rats; MCT2 expression increased mainly in adult rats. At all ages, MCT1 and MCT2 up-regulation was limited to the circuit of seizures while GLUT1 and GLUT3 changes were more widespread. During the latent and chronic phases, the expression of nutrient transporters was normal in PN10 rats. In PN21 rats, GLUT1 was up-regulated in all brain regions. In contrast, in adult rats GLUT1 expression was down-regulated in the piriform cortex, hilus and CA1 as a result of extensive neuronal death. The changes in nutrient transporter expression reported here further support previous findings in other experimental models demonstrating rapid transcriptional responses to marked changes in cerebral energetic/glucose demand.
AB - The lithium-pilocarpine model mimics most features of human temporal lobe epilepsy. Following our prior studies of cerebral metabolic changes, here we explored the expression of transporters for glucose (GLUT1 and GLUT3) and monocarboxylates (MCT1 and MCT2) during and after status epilepticus (SE) induced by lithium-pilocarpine in PN10, PN21, and adult rats. In situ hybridization was used to study the expression of transporter mRNAs during the acute phase (1, 4, 12 and 24 h of SE), the latent phase, and the early and late chronic phases. During SE, GLUT1 expression was increased throughout the brain between 1 and 12 h of SE, more strongly in adult rats; GLUT3 increased only transiently, at 1 and 4 h of SE and mainly in PN10 rats; MCT1 was increased at all ages but 5-10-fold more in adult than in immature rats; MCT2 expression increased mainly in adult rats. At all ages, MCT1 and MCT2 up-regulation was limited to the circuit of seizures while GLUT1 and GLUT3 changes were more widespread. During the latent and chronic phases, the expression of nutrient transporters was normal in PN10 rats. In PN21 rats, GLUT1 was up-regulated in all brain regions. In contrast, in adult rats GLUT1 expression was down-regulated in the piriform cortex, hilus and CA1 as a result of extensive neuronal death. The changes in nutrient transporter expression reported here further support previous findings in other experimental models demonstrating rapid transcriptional responses to marked changes in cerebral energetic/glucose demand.
UR - http://www.scopus.com/inward/record.url?scp=79960230764&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=79960230764&partnerID=8YFLogxK
U2 - 10.1016/j.nbd.2011.05.007
DO - 10.1016/j.nbd.2011.05.007
M3 - Article
C2 - 21624469
AN - SCOPUS:79960230764
SN - 0969-9961
VL - 43
SP - 588
EP - 597
JO - Neurobiology of Disease
JF - Neurobiology of Disease
IS - 3
ER -